RevMed
Home/Specialty/Microbiology

Microbiology

13,132 Results
Results Per Page
  • 50
  • 100
  • 250
Catalog #
Qty
Starting At
Name
Company Name
Description
0
-
VITEK® 2 AST-N808
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N807
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N806
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N809
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-XN32
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-XN31
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-XN30
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
VITEK® 2 AST-N804
BIOMERIEUX , INC.
VITEK® 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems to determine the susceptibility of clinically significant aerobic gram-negative bacilli
0
-
BACT/ALERT
BIOMERIEUX , INC.
R3.1 SW/FW for BACT/ALERT VIRTUO
0
-
VITEK® MS knowledge base v3.3
BIOMERIEUX SA
VITEK® MS knowledge base v3.3
0
-
VITEK® 2 KB UPDATE V2S
BIOMERIEUX , INC.
Knowledge Base Update for VITEK2 Software
0
-
VITEK®MS
BIOMERIEUX SA
VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument
0
-
ETEST® Tobramycin (TM)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
ETEST® Sulbactam/Durlobactam (SUD)
BIOMERIEUX SA
ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
0
-
Nano-Check RSV Test
NANO-DITECH CORPORATION
The Nano-Check RSV Test is a rapid immunochromatographic assay for the qualitative detection of respiratory syncytial virus (RSV) nucleoprotein antigen in anterior nasal swab specimens from patients with signs and symptoms of respiratory infection. This test is intended for in vitro diagnostic use to aid in the diagnosis of RSV infections in infants and pediatric patients aged 6 months to 6 years old, and adults over 60 years of age.
0
-
Nano-Check Influenza+COVID-19 Dual Test
NANO-DITECH CORPORATION
The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. The Nano-Check™ Influenza+COVID-19 Dual Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. This product has not been cleared or approved.
0
-
Nano-CheckTM PCT plus
NANO-DITECH CORPORATION
In Vitro Diagnostic Test kit for the determination of Procalcitonin in human whole blood, serum and plasma
0
-
Fluoro-CheckTM PCT
NANO-DITECH CORPORATION
Fluorescence In Vitro diagnostic test kit for the detection of Procalcitonin in human whole blood, serum or plasma
0
-
Nano-CheckTM PCT
NANO-DITECH CORPORATION
In Vitro Diagnostic Test kit for the determination of Procalcitonin in human whole blood, plasma or serum
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Ascaris IgG ELISAFor the qualitative detection of immunoglobulin G (IgG) antibodies to the parasitic nematode Ascaris lumbricoides in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag ™Mycoplasma pneumoniae IgM Test System provides a means for the qualitative detection of IgM antibodies to Mycoplasma pneumoniae in human sera.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Trichinella IgG ELISA - For the qualitative detection of immunoglobulin G (IgG) antibodies to the parasitic nematode Trichinella species in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Taenia.solium (Cysticercosis) IgG ELISA -For the qualitative and/or quantitative detection of immunoglobulin G (IgG) antibodies to Taenia solium in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Fasciola IgG ELISA
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Echinococcus IgG ELISA
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag™ Schistosoma IgG ELISA - For the qualitative detection of immunoglobulin G (IgG) antibodies to multiple species of the parasitic flatworm Schistosoma in a clinical specimen, using an enzyme immunoassay (EIA) method.
0
-
AccuDiag ™
Diagnostic Automation, Inc.
AccuDiag ™ Varicella-Zoster Virus (VZV) IgG Enzyme-linked Immunosorbent Assay (ELISA) is intended for the detection and quantitative determination of IgG antibody to VZV in human sera.
0
-
Journey II
Smith & Nephew
JOURNEY II AP CUTTING BLOCK - SIZE 3
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m EBV Application Specification File
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m STI Application Specification File
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m CMV Application Specification File
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m HCV Application Specification File
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m HIV-1 Application Specification File
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m HSV 1 & 2 / VZV AMP Kit
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m HSV 1 & 2 / VZV CTRL Kit
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m HSV 1 & 2 / VZV Application Specification File
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m CMV Application Specification File
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m CMV AMP Kit
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m CMV CTRL Kit
0
-
Alinity m
ABBOTT MOLECULAR INC.
Alinity m CMV CAL Kit
0
-
RealTime
ABBOTT MOLECULAR INC.
Abbott RealTime CMV m2000 System Combined Application CD-ROM
0
-
RealTime
ABBOTT MOLECULAR INC.
Abbott Proteinase K Recombinant, PCR Grade
0
-
RealTime
ABBOTT MOLECULAR INC.
Abbott RealTime CMV Amplification Reagent Kit
0
-
RealTime
ABBOTT MOLECULAR INC.
Abbott RealTime CMV Control Kit
0
-
RealTime
ABBOTT MOLECULAR INC.
Abbott RealTime CMV Calibrator Kit
0
-
cobas® SARS-CoV-2 Qualitative 480T
Roche Molecular Systems, Inc.
0
-
cobas® SARS-CoV-2 Qualitative Control Kit
Roche Molecular Systems, Inc.
0
-
cobas® SARS-CoV-2 Qualitative 192T
Roche Molecular Systems, Inc.